Avanir Pharmaceuticals Announces Listing Of Additional NUEDEXTA Patent In FDA Orange Book
03:48 EDT 6 Aug 2012 | PR Newswire
This article has expired, however you can still
download the PDF.
Preview:
ALISO VIEJO, Calif., Aug. 3, 2012 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) announced today that an additional patent covering Avanir's NUEDEXTA® (dextromethorphan HBr and quinidine sulfate) product has been listed in the U.S. F...
Other Sources for this Article
More From BioPortfolio on "Avanir Pharmaceuticals Announces Listing Of Additional NUEDEXTA Patent In FDA Orange Book"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
